Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy-Reference-Cited by-同舟云学术

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy

Published:2021-06-13 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Naik Adviti¹^ORCID,Decock Julie¹^ORCID

Affiliation:

1. Translational Cancer and Immunity Center Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU) Qatar Foundation (QF) Doha Qatar

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13024

Reference71 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

3. Molecular portraits of human breast tumours

4. Intrinsic Subtypes from the PAM50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort: Prognostication of Short- and Long-term Outcomes

5. Molecular Classification of Triple-Negative Breast Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recent perspective on designing tumor vaccines for tumor immunology;International Immunopharmacology;2024-12

2. Denoiseit: denoising gene expression data using rank based isolation trees;BMC Bioinformatics;2024-08-21

3. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy;Genes & Genomics;2024-08-10

4. The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival;Cancers;2024-07-04

5. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer;Molecular Therapy: Oncology;2024-03